Status:
COMPLETED
Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Lead Sponsor:
Eysz, Inc.
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Absence Epilepsy, Childhood
Absence Seizures
Eligibility:
All Genders
4-12 years
Brief Summary
This study is being done to find out if a smartphone app can identify absence seizures. Children who have a history of absence seizures, as well as children without any seizure history, will be testin...
Detailed Description
This observational study focuses on validating the use of the Eysz mHealth App - a smartphone-based tool for guided Hyperventilation (HV) and data collection - to aid clinicians in identifying absence...
Eligibility Criteria
Inclusion
- typical absence seizure during use of the Eysz Hyperventilation Recorder or Control
Exclusion
- Other seizure type besides typical absence seizure during use of the Eysz Hyperventilation Recorder
- subclinical seizure activity
- inability to participate with study procedures
- contraindications to hyperventilation including history of subarachnoid hemorrhage, sickle cell anemia, recent cerebrovascular accident or myocardial infarction, significant cardiopulmonary disease, active asthma, known aneurysm, known moyamoya disease, or pregnancy.
- People who have a history of generalized tonic clonic convulsions (GTCs) provoked by hyperventilation
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06093490
Start Date
December 1 2023
End Date
July 30 2025
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 045229